BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 35266872)

  • 1. RWD-Cockpit: Application for Quality Assessment of Real-world Data.
    Babrak LM; Smakaj E; Agac T; Asprion PM; Grimberg F; der Werf DV; van Ginkel EW; Tosoni DD; Clay I; Degen M; Brodbeck D; Natali EN; Schkommodau E; Miho E
    JMIR Form Res; 2022 Oct; 6(10):e29920. PubMed ID: 35266872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Clinical Data Interchange Standards Consortium (CDISC) Standards for Real-world Data: Expert Perspectives From a Qualitative Delphi Survey.
    Facile R; Muhlbradt EE; Gong M; Li Q; Popat V; Pétavy F; Cornet R; Ruan Y; Koide D; Saito TI; Hume S; Rockhold F; Bao W; Dubman S; Jauregui Wurst B
    JMIR Med Inform; 2022 Jan; 10(1):e30363. PubMed ID: 35084343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. It is important to note that RWD will never replace the more traditional and more robust RCT data; however, the emerging trend is to incorporate data that are more generalizable. Introduction.
    Mullins CD; Sanchez RJ
    J Manag Care Pharm; 2011; 17(9 Suppl A):S03-4. PubMed ID: 22074667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary Attainability Assessment of Real-World Data for Answering Major Clinical Research Questions in Breast Cancer Brain Metastasis: Framework Development and Validation Study.
    Kim MJ; Kim HJ; Kang D; Ahn HK; Shin SY; Park S; Cho J; Park YH
    J Med Internet Res; 2023 Mar; 25():e43359. PubMed ID: 36951923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Data Governance for Real-World Data Management: A Proposal for a Checklist to Support Decision Making.
    Solà-Morales O; Sigurðardóttir K; Akehurst R; Murphy LA; Mestre-Ferrandiz J; Cunningham D; de Pouvourville G
    Value Health; 2023 Apr; 26(4S):32-42. PubMed ID: 36870678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-World Data as External Controls: Practical Experience from Notable Marketing Applications of New Therapies.
    Izem R; Buenconsejo J; Davi R; Luan JJ; Tracy L; Gamalo M
    Ther Innov Regul Sci; 2022 Sep; 56(5):704-716. PubMed ID: 35676557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality Criteria for Real-world Data in Pharmaceutical Research and Health Care Decision-making: Austrian Expert Consensus.
    Klimek P; Baltic D; Brunner M; Degelsegger-Marquez A; Garhöfer G; Gouya-Lechner G; Herzog A; Jilma B; Kähler S; Mikl V; Mraz B; Ostermann H; Röhl C; Scharinger R; Stamm T; Strassnig M; Wirthumer-Hoche C; Pleiner-Duxneuner J
    JMIR Med Inform; 2022 Jun; 10(6):e34204. PubMed ID: 35713954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transferability of real-world data across borders for regulatory and health technology assessment decision-making.
    Jaksa A; Arena PJ; Chan KKW; Ben-Joseph RH; Jónsson P; Campbell UB
    Front Med (Lausanne); 2022; 9():1073678. PubMed ID: 36465931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world evidence to support Payer/HTA decisions about highly innovative technologies in the EU-actions for stakeholders.
    Facey KM; Rannanheimo P; Batchelor L; Borchardt M; de Cock J
    Int J Technol Assess Health Care; 2020 Sep; ():1-10. PubMed ID: 32878663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of Real-World Evidence in European Medicines Agency's Regulatory Decision Making.
    Bakker E; Plueschke K; Jonker CJ; Kurz X; Starokozhko V; Mol PGM
    Clin Pharmacol Ther; 2023 Jan; 113(1):135-151. PubMed ID: 36254408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raising the Bar for Real-World Data in Oncology: Approaches to Quality Across Multiple Dimensions.
    Castellanos EH; Wittmershaus BK; Chandwani S
    JCO Clin Cancer Inform; 2024 Jan; 8():e2300046. PubMed ID: 38241599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world data for health technology assessment for reimbursement decisions in Asia: current landscape and a way forward.
    Lou J; Kc S; Toh KY; Dabak S; Adler A; Ahn J; Bayani DBS; Chan K; Choiphel D; Chua B; Genuino AJ; Guerrero AM; Kearney B; Lin LW; Liu Y; Nakamura R; Pearce F; Prinja S; Pwu RF; Shafie AA; Sui B; Suwantika A; Teerawattananon Y; Tunis S; Wu HM; Zalcberg J; Zhao K; Isaranuwatchai W; Wee HL
    Int J Technol Assess Health Care; 2020 Oct; 36(5):474-480. PubMed ID: 32928330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-world outcomes associated with new cancer medicines approved by the Food and Drug Administration and European Medicines Agency: A retrospective cohort study.
    Boyle JM; Hegarty G; Frampton C; Harvey-Jones E; Dodkins J; Beyer K; George G; Sullivan R; Booth C; Aggarwal A
    Eur J Cancer; 2021 Sep; 155():136-144. PubMed ID: 34371443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reality check: Real-world evidence to support therapeutic development in hematologic malignancies.
    Derman BA; Belli AJ; Battiwalla M; Hamadani M; Kansagra A; Lazarus HM; Wang CK
    Blood Rev; 2022 May; 53():100913. PubMed ID: 35272867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-World Evidence: A Primer.
    Zura R; Irwin DE; Mack CD; Aldridge ML; Mackowiak JI
    J Orthop Trauma; 2021 Mar; 35(Suppl 1):S1-S5. PubMed ID: 33587539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Real-World Data Challenges Radar: A Review on the Challenges and Risks regarding the Use of Real-World Data.
    Grimberg F; Asprion PM; Schneider B; Miho E; Babrak L; Habbabeh A
    Digit Biomark; 2021; 5(2):148-157. PubMed ID: 34414352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health and Healthcare: Assessing the Real World Data Policy Landscape in Europe.
    Miani C; Robin E; Horvath V; Manville C; Cave J; Chataway J
    Rand Health Q; 2014; 4(2):15. PubMed ID: 28083344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world data in oncology: a questionnaire-based analysis of the academic research landscape examining the policies and experiences of the cancer cooperative groups.
    Saesen R; Lacombe D; Huys I
    ESMO Open; 2023 Apr; 8(2):100878. PubMed ID: 36822113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.